Featured Research

from universities, journals, and other organizations

Lung cancer survivors experience long-term effects of breathlessness

Date:
August 3, 2010
Source:
International Association for the Study of Lung Cancer
Summary:
With the growing number of long-term lung cancer survivors, research is needed to identify and address cancer survivorship issues. One of the most common and debilitating symptoms among lung cancer patients is dyspnea, or shortness of breath. As most studies of dyspnea have reviewed patients with active lung cancer or immediately after treatment, the prevalence of dyspnea over the long-term once treatment has been completed is not well characterized.

With the growing number of long-term lung cancer survivors, research is needed to identify and address cancer survivorship issues. One of the most common and debilitating symptoms among lung cancer patients is dyspnea, or shortness of breath. As most studies of dyspnea have reviewed patients with active lung cancer or immediately after treatment, the prevalence of dyspnea over the long-term once treatment has been completed is not well characterized.

In a study featured in the August edition of the Journal of Thoracic Oncology, Marc B. Feinstein, MD describes the prevalence and severity of dyspnea in long-term lung cancer survivors and provides specific factors associated with the condition that may help clinicians target post-treatment rehabilitation strategies. Dr. Feinstein and fellow researchers at Memorial Sloan-Kettering Cancer Center and UMDNJ-Robert Wood Johnson Medical School surveyed 342 early-stage lung cancer survivors, who had their tumor removed within one to six years of the survey. Within this population of cancer survivors, dypsnea was found in 205 individuals (60 percent), nearly three-fold the number of patients who presented with dyspnea before their surgery (21 percent).

Additional findings showed that factors associated with long-term dyspnea in cancer survivors included presence of dyspnea before lung cancer surgery, reduced diffusion capacity (lung's ability to transfer oxygen into the blood) and lack of physical activity. Depression symptoms also were assessed, but were not very prevalent in the study sample (occurring among 10 percent of lung cancer survivors), but were nonetheless strongly associated with dyspnea.

"The identification of potentially modifiable risk factors associated with dyspnea is perhaps the most significant finding," affirms Marc Feinstein, MD, assistant attending physician in the Pulmonary Service at Memorial Sloan-Kettering Cancer Center. "This implies that strategies which improve physical activity or relieve depressive symptoms may results in improved breathlessness."

Researchers concluded that future research is needed to test whether screening and intervening for depression and physical inactivity among lung cancer survivors improves dyspnea is long-term lung cancer survivors.


Story Source:

The above story is based on materials provided by International Association for the Study of Lung Cancer. Note: Materials may be edited for content and length.


Cite This Page:

International Association for the Study of Lung Cancer. "Lung cancer survivors experience long-term effects of breathlessness." ScienceDaily. ScienceDaily, 3 August 2010. <www.sciencedaily.com/releases/2010/08/100802131124.htm>.
International Association for the Study of Lung Cancer. (2010, August 3). Lung cancer survivors experience long-term effects of breathlessness. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2010/08/100802131124.htm
International Association for the Study of Lung Cancer. "Lung cancer survivors experience long-term effects of breathlessness." ScienceDaily. www.sciencedaily.com/releases/2010/08/100802131124.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins